Detection and clinical importance of micrometastatic disease.
about
Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancerOptimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cellsRecent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients.Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceScreening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization.Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapyA highly sensitive and specific system for large-scale gene expression profilingUse of automated microscopy for the detection of disseminated tumor cells in bone marrow samples.Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line.Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cellsSerial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trialAssociation of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patientsMicrophthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients"Pre-metastatic niches" in breast cancer: are they created by or prior to the tumour onset? "Flammer Syndrome" relevance to address the question.Interactions between cancer cells and the endothelium in metastasis.Pathophysiologic interactions in skeletal metastasis.The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumorsBioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cellsCombined transcriptome and genome analysis of single micrometastatic cells.From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow.Cytokeratins and other sensitive markers for esophageal cancer and metastases.Technical aspects of minimal residual disease detection in carcinoma patients.Characterization of disseminated tumor cells.Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowRisk factors for distant metastasis as a primary site of treatment failure in early-stage breast cancer.A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancerCytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.The detection of circulating breast cancer cells in blood.Design of a real time quantitative PCR assay to assess global mRNA amplification of small size specimens for microarray hybridisationCentral nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu statusHigh prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancerMutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level.Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]
P2860
Q21260405-6BB0A753-EC01-46AF-858B-79E2FDAE90F4Q24794019-FB71FD3E-3C69-490B-B1FD-FEA7734D5F51Q24801607-0AFCC1E9-B270-45D9-BF5E-A706A3FAF174Q24806218-843BEA86-8FD8-494A-AE96-9C4C08D68A82Q24811648-2F8D5E2D-1395-4AAE-BAF0-E98BF9EB0AB5Q28544732-325D02D9-552B-43C3-8655-C2BA672937ABQ28755360-D87DE0FD-4EDD-4209-9445-CAA43381E8ECQ30701696-64B10130-FC76-4F48-B1AF-C0C7CE1FEE05Q30887474-8AD84A65-AC44-43B9-80D6-8C33C38C2D3DQ30993283-C03973D3-C440-4EA9-B673-55E7B0328AA9Q33285246-C1D08024-9B65-4D41-A46B-7A0D3CFEC786Q33794086-791CEB1D-B5CE-4FB3-AB98-BE6844FEFE80Q33796997-DB30B2F8-F2E3-4C36-BD22-63B478826EBCQ33797039-6B852C7D-8F73-401B-AF75-031115F823BEQ33797088-3DFAD815-F56D-42BB-A76E-9637032872A2Q33797133-373875DB-8387-44B5-B354-59557DFB5076Q33840723-9397039B-4185-4D94-868D-74B433F5117CQ33843565-6C9E6A15-62DD-46D4-A37E-B28614E523B7Q33970469-79D61924-BE81-4909-9892-D04F1BD69CE2Q33977304-FAFE6286-AD07-43EA-90A3-20A0293C432FQ34012916-6F686282-539C-4B16-B510-FEE3EEF62FE7Q34055939-3DE18F96-82C1-4316-B109-797CEE1B8BEDQ34121277-A57FF5F4-9106-4A43-8E9F-E8D360185992Q34206149-43FF8E53-54D1-4CF8-BCEC-D9166B525292Q34274752-A8EC6915-A611-43A3-A0ED-D218232701E9Q34284347-C2C058C8-90EC-4266-9B86-08D3D91FF3FBQ34366103-D8A0FF4C-978D-4701-83ED-3469C01481D1Q34465167-A35D70BD-5F8E-4154-B1EE-6018D8DB4F11Q34465174-379465D8-D6D1-47D6-AAFF-DF4D47502FA1Q34600828-DE283360-269E-4EF4-BDDA-BFFF4F195C18Q34755120-043C14F7-C665-44CE-A194-59F192329284Q34774308-8F3E12AD-DC44-4701-9291-C2C24653CAB2Q35034712-325F06DA-9F9D-49F3-83AE-51035F921DF1Q35558096-17CD53AD-AA82-470C-ABC7-FE30F665F947Q35587910-D03AFECF-3D6F-4D3C-AB08-7A26C8816926Q35588175-E3648616-F9FD-433B-B1D6-7D55B58D4666Q35605745-70215F9F-A6DC-4BD2-A215-43121B11DE60Q35770268-30824005-8F89-49C3-8346-95915A102657Q35835111-1EA178BC-5701-4A75-B810-5C9B8B10D85AQ35870328-6425476D-D9FD-4F18-B9DE-99317DDBED0F
P2860
Detection and clinical importance of micrometastatic disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Detection and clinical importance of micrometastatic disease.
@ast
Detection and clinical importance of micrometastatic disease.
@en
type
label
Detection and clinical importance of micrometastatic disease.
@ast
Detection and clinical importance of micrometastatic disease.
@en
prefLabel
Detection and clinical importance of micrometastatic disease.
@ast
Detection and clinical importance of micrometastatic disease.
@en
P2093
P2860
P356
P1476
Detection and clinical importance of micrometastatic disease.
@en
P2093
P2860
P304
P356
10.1093/JNCI/91.13.1113
P407
P577
1999-07-01T00:00:00Z